EF-2001
PB PROPOSAL
DATA

EFFECT

Anti-Tumour Effect

Anti-Allergy Effect

Intestinal Flora Improvement Effect

Comparison of Immunity-Specific Activity by Bacteria Type

Radioprotective Effect

Immunity-Boosting Effect

Intestinal Pathogen Preventative Effect

Edema Inhibitory Effect

Birth Defect Prevention Effect

Anti-diabetic Effect

Blood Pressure Elevation Inhibition and Improved Liver Function Effects

Cancer Treatment Clinic (1)

- Hyperthermic cancer treatment enhancing effect

- Hyperthermic treatment CT1

- Hyperthermic treatment CT2

- Hyperthermic treatment CT3

Radiotherapy Clinic (2)

- Combined effect with radiotherapy

- Radiotherapy CT1

- Radiotherapy CT2

- Radiotherapy CT3

- Radiotherapy CT4

- Radiotherapy CT5

Overview of Conference Presentations on Immunobiotic Lactic Acid Bacteria EF-2001

Overview of Theses on Immunobiotic Lactic Acid Bacteria EF-2001

COMPANY INFO.
TERM
PUBLICATIONS/VIDEOS

Immunity-boosting effect in mice that have ingested EF-2001 in a state of lowered resistance


Mice were administered feed containing 10% EF-2001 for a two-week period. They were then administered immunosuppressant cyclophosphamide (CY) to put them into a state of lowered resistance, followed by an injection of E. coli from the tail vein. The number of bacteria in the liver was measured over time.

※P < 0.05 P < 0.01



The EF-2001 group showed markedly fewer E. coli bacteria in the liver than the control group, indicating a non-specific immunity-boosting effect.


   

Copyright© 2013 NIHON BERUMU CO.,LTD ALL Rights Reserved